active
ACTIVE SINCE: 2020

Ending Workplace TB

Launched in 2020, the Global Fund to Fight AIDS, TB and Malaria, the Stop TB Partnership, World Economic Forum and the private sector came together to leverage the untapped potential of private businesses in high TB-burden countries and roll out awareness, detection and treatment programs to reach workforces and their families and communities.
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Bilateral development organizations 1
Global NGOs 1
Intergovernmental Organizations and Multilaterals 2
Objectives

The collaboration aims to identify, diagnose and ultimately treat people living with TB by leveraging the untapped potential of businesses.

What are the health needs and challenges?

Until the emergence of COVID-19, tuberculosis (TB) claimed more lives each year than any other infectious disease. The continued spread of this deadly, airborne and contagious respiratory infection, which disproportionately impacts the world’s poorest and most vulnerable populations, is driven in part by the “missing millions” of people who are not formally diagnosed. This means that people living with this highly contagious disease cannot be treated, putting their health, and that of their families and communities, at risk.

This problem is particularly acute for businesses. Unlike many other diseases, TB tends to impact people during their most productive years – from 15 to 65 years of age. People sickened by TB often miss time, underperform or even drop out of work altogether, which in addition to creating a cycle of poverty and poor health that is exceptionally difficult to break, comes at an extraordinary economic price. A 2019 report shows that drug-resistant TB (DR-TB), in addition to causing sickness, suffering and death, is throttling the global economy and will cost approximately $17 trillion by 2050 if left unaddressed – a burden shared disproportionately by high TB-burden countries and the companies they host.

Collaboration activities and how they address needs and challenges

Johnson & Johnson—along with the World Economic Forum, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Stop TB Partnership, Royal Philips, Fullerton Health, and the United States Agency for International Development (USAID)—launched the Ending Workplace TB Initiative at Davos in January 2020. Together, the companies that comprise Ending Workplace TB are identifying and connecting more people to TB care and treatment, while improving productivity and reducing costs related to health care, staff turnover and absenteeism.

Results and milestones

Now in its third year, the coalition has grown to more than 50 companies – 80% of which had no engagement in the fight against TB before – who are dedicated to fighting TB among their 4 million direct employees and untold millions more in supply chains and contractors worldwide.

Geographic Reach
  • Global Commitment
Disease Area
  • Infectious and Parasitic Disease
See Disease Areas
Partner organizations
Bilateral development organizations

US Agency for International Development (USAID)

Global NGOs

Stop TB Partnership

Intergovernmental Organizations and Multilaterals

World Economic Forum (WEF)

Global Fund to Fight AIDS, Tuberculosis and Malaria

Additional resources

FURTHER READING